GlaxoSmithKline is suspending the use of 170,000 doses of its new H1N1 influenza vaccine in Canada. This is due to a higher-than-usual rate of reported side effects potentially linked to the vaccine.
Potential side effects were rooted from allergic reactions suffered by six people that experienced breathing difficulties and reduced blood pressure in the Canadian province of Manitoba. Side effects are very common for any medication, with a typical ratio of 1.5 : 170,000. It has been reported that all six recovered after a short time.
Flu Shots in the United States are unaffected and are still highly recommended by the AMA and CDC.
Find a flu shot closest to your home at medtipster.com.